Acceptability, Usability and Preliminary Effectiveness of ChatGPT in Increasing Seasonal Influenza Vaccination Uptake Among Older Adults in Hong Kong

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorChinese University of Hong Kong

About this trial

In this project, we will train a ChatGPT to provide real-time answers to questions related to the SIV for older adults in Hong Kong.

This study aims to evaluate the usability, acceptability, and preliminary effectiveness of the ChatGPT among 50 community-living people aged 65 years and above in Hong Kong.

The primary objectives are to evaluate the usability and acceptability (including the extent of usage and subjective experiences of behavioural, cognitive, and affective engagement) of the ChatGPT at the end of the 4-week intervention period (T1).

The secondary objectives are to evaluate the following conditions measured at T1, as compared to those measured at baseline (T0):

1. Self-reported uptake of SIV in the past month. 2. Changes in behavioural intention to receive SIV for the approaching flu season. 3. Changes in knowledge and attitudes related to SIV.

Eligibility criteria

Qualifiers

Aged ≥65 years;

Possession of a Hong Kong ID;

Able to speak and comprehend Cantonese;

Have a smartphone with internet access;

Disqualifiers

With diagnosis of cognitive impairment or dementia;

Either blindness or deafness;

With known contraindications to the SIV as indicated by the Hong Kong Centre for Health Protection

Trial design

Treatments tested in this trial

  • Access to a trained ChatGPT

Treatment groups

50 Participants
are divided into 1 treatment group

Locations

This trial has no locations